Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Direct treatment costs of HIV/AIDS in Portugal.
Perelman J, Alves J, Miranda AC, Mateus C, Mansinho K, Antunes F, Oliveira J, Poças J, Doroana M, Marques R, Teófilo E, Pereira J. Perelman J, et al. Among authors: teofilo e. Rev Saude Publica. 2013 Oct;47(5):865-72. doi: 10.1590/s0034-8910.2013047004598. Rev Saude Publica. 2013. PMID: 24626490 Free article.
The demise of multidrug-resistant HIV-1: the national time trend in Portugal.
Vercauteren J, Theys K, Carvalho AP, Valadas E, Duque LM, Teófilo E, Faria T, Faria D, Vera J, Aguas MJ, Peres S, Mansinho K, Vandamme AM, Camacho RJ; Portuguese HIV-1 Resistance Study Group. Vercauteren J, et al. Among authors: teofilo e. J Antimicrob Chemother. 2013 Apr;68(4):911-4. doi: 10.1093/jac/dks470. Epub 2012 Dec 9. J Antimicrob Chemother. 2013. PMID: 23228933 Free PMC article.
HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.
Cavaco-Silva J, Abecasis A, Miranda AC, Poças J, Narciso J, Águas MJ, Maltez F, Almeida I, Germano I, Diniz A, Gonçalves Mde F, Gomes P, Cunha C, Camacho RJ; Portuguese HIV-2 Resistance Study Group. Cavaco-Silva J, et al. PLoS One. 2014 Mar 28;9(3):e92747. doi: 10.1371/journal.pone.0092747. eCollection 2014. PLoS One. 2014. PMID: 24681625 Free PMC article.
HIV-1-Transmitted Drug Resistance and Transmission Clusters in Newly Diagnosed Patients in Portugal Between 2014 and 2019.
Pingarilho M, Pimentel V, Miranda MNS, Silva AR, Diniz A, Ascenção BB, Piñeiro C, Koch C, Rodrigues C, Caldas C, Morais C, Faria D, da Silva EG, Teófilo E, Monteiro F, Roxo F, Maltez F, Rodrigues F, Gaião G, Ramos H, Costa I, Germano I, Simões J, Oliveira J, Ferreira J, Poças J, da Cunha JS, Soares J, Henriques J, Mansinho K, Pedro L, Aleixo MJ, Gonçalves MJ, Manata MJ, Mouro M, Serrado M, Caixeiro M, Marques N, Costa O, Pacheco P, Proença P, Rodrigues P, Pinho R, Tavares R, de Abreu RC, Côrte-Real R, Serrão R, Castro RSE, Nunes S, Faria T, Baptista T, Martins MRO, Gomes P, Mendão L, Simões D, Abecasis A. Pingarilho M, et al. Among authors: teofilo e. Front Microbiol. 2022 Apr 25;13:823208. doi: 10.3389/fmicb.2022.823208. eCollection 2022. Front Microbiol. 2022. PMID: 35558119 Free PMC article.
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H; BENCHMRK Study Teams. Eron JJ, et al. Lancet Infect Dis. 2013 Jul;13(7):587-96. doi: 10.1016/S1473-3099(13)70093-8. Epub 2013 May 7. Lancet Infect Dis. 2013. PMID: 23664333 Free PMC article. Clinical Trial.
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, Pozniak A, Thompson M, Podzamczer D, Molina JM, Oka S, Koenig E, Trottier B, Andrade-Villanueva J, Crofoot G, Custodio JM, Plummer A, Zhong L, Cao H, Martin H, Callebaut C, Cheng AK, Fordyce MW, McCallister S; GS-US-292-0104/0111 Study Team. Sax PE, et al. Lancet. 2015 Jun 27;385(9987):2606-15. doi: 10.1016/S0140-6736(15)60616-X. Epub 2015 Apr 15. Lancet. 2015. PMID: 25890673 Clinical Trial.
Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study.
Teófilo E, Rocha-Pereira N, Kuhlmann B, Antela A, Knechten H, Santos J, Jiménez-Expósito MJ; REMAIN study group. Teófilo E, et al. HIV Clin Trials. 2016 Feb;17(1):17-28. doi: 10.1080/15284336.2015.1112494. HIV Clin Trials. 2016. PMID: 26899539 Free PMC article. Clinical Trial.
42 results